A Study to Evaluate the Safety and Immunogenicity of an Adjuvanted RSV Vaccine in Healthy Older Adults

Clinical trial NCT03572062 · TERMINATED

Trial details

NCT number: NCT03572062
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Respiratory Tract Infection

Start date: 2018-06-05
Primary completion: 2020-06-23
Enrollment: 317

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.